06 Oct 2025 | 3 Mins Read
Zydus Lifesciences approved for Canadian Liothyronine tablets
Flipitmoney
Zydus Lifesciences received a Notice of Compliance from Health Canada for generic Liothyronine tablets in 5 mcg and 25 mcg strengths. The product treats hypothyroidism with annual sales of 10.9 million Canadian dollars in Canada. Zydus will market the drug in Canada, expanding its North American generics market presence.